Transplantation, AutologousMultiple MyelomaHematopoietic Stem Cell TransplantationStem Cell TransplantationMelphalanPeripheral Blood Stem Cell TransplantationTransplantation, HomologousTransplantation ConditioningCombined Modality TherapyAntineoplastic Combined Chemotherapy ProtocolsRemission InductionTreatment OutcomeStem CellsSalvage TherapyDisease-Free SurvivalBoronic AcidsMyeloablative AgonistsHodgkin DiseasePyrazinesRecurrenceEtoposideLymphoma, Non-HodgkinCyclophosphamideCytarabineCarmustineHematopoietic Stem Cell MobilizationGraft vs Host DiseaseVincristineBone Marrow TransplantationThalidomideSurvival RateBone Marrow PurgingThiotepaHematologic NeoplasmsDexamethasoneAmyloidosisSurvival AnalysisWhole-Body IrradiationRetrospective StudiesLymphoma, Mantle-CellHematopoietic Stem CellsBusulfanGraft SurvivalPrognosisDoxorubicinAntineoplastic Agents, AlkylatingAutograftsAntigens, CD34Antibodies, Monoclonal, Murine-DerivedLymphoma, FollicularFollow-Up StudiesLymphoma, T-Cell, PeripheralPrednisoneLiver TransplantationLeukemia, Plasma CellMesenchymal Stem Cell TransplantationLeukapheresisLymphomaTime FactorsMaintenance ChemotherapyInduction ChemotherapyAntineoplastic AgentsGranulocyte Colony-Stimulating FactorIfosfamidePodophyllotoxinMyeloma ProteinsTransplantation ChimeraNeoplasm, ResidualLymphoma, Large B-Cell, DiffuseTissue DonorsCord Blood Stem Cell TransplantationCell TransplantationLeukemia, Myeloid, AcuteKidney TransplantationLymphoma, B-CellBone MarrowEnteropathy-Associated T-Cell LymphomaEmbryonic Stem CellsMyelodysplastic SyndromesImmunoglobulin Light ChainsInfusions, SpinalNeoplasms, Second PrimaryBlood Component RemovalIdarubicinPlasma CellsAdult Stem CellsImmunosuppressive AgentsMitoxantroneParaproteinemiasAntibodies, MonoclonalHistocompatibility TestingProspective StudiesKeratins, Type IICell DifferentiationFatal OutcomeBone Marrow CellsLife TablesFeasibility StudiesMesenchymal Stromal CellsLeukemia